Hu J - Search Results

1

Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors.

Liu J, Nie M, Wang Y, Hu J, Zhang F, Gao Y, Liu Y, Gong P. Liu J, et al. Among authors: hu j. Eur J Med Chem. 2016 Nov 10;123:431-446. doi: 10.1016/j.ejmech.2016.07.059. Epub 2016 Jul 26. Eur J Med Chem. 2016. PMID: 27490023

2

Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors.

Liu Z, Wang R, Guo R, Hu J, Li R, Zhao Y, Gong P. Liu Z, et al. Among authors: hu j. Bioorg Med Chem. 2014 Jul 15;22(14):3642-53. doi: 10.1016/j.bmc.2014.05.013. Epub 2014 May 17. Bioorg Med Chem. 2014. PMID: 24882675

3

Discovery of selective EGFR modulator to inhibit L858R/T790M double mutants bearing a N-9-Diphenyl-9H-purin-2-amine scaffold.

Hu J, Han Y, Wang J, Liu Y, Zhao Y, Liu Y, Gong P. Hu J, et al. Bioorg Med Chem. 2018 May 1;26(8):1810-1822. doi: 10.1016/j.bmc.2018.02.029. Epub 2018 Feb 17. Bioorg Med Chem. 2018. PMID: 29486953

4

Palladium-Catalyzed Cyclization Reaction of Oxime Acetates and Aryl Iodides: Syntheses of 2-Imidazolines.

Hu J, Li Z, Zhang X, Han Y, Liu Y, Zhao Y, Liu Y, Gong P. Hu J, et al. Org Lett. 2018 Apr 6;20(7):2116-2119. doi: 10.1021/acs.orglett.8b00696. Epub 2018 Mar 19. Org Lett. 2018. PMID: 29553756

5

Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing a 4,5,6,7-tetrahydrothieno [3,2-c]pyridine as potent EGFR inhibitors.

Li Y, Chang Y, Fu J, Ding R, Zhang L, Liang T, Liu Y, Liu Y, Hu J. Li Y, et al. Among authors: hu j. Eur J Med Chem. 2021 Dec 15;226:113845. doi: 10.1016/j.ejmech.2021.113845. Epub 2021 Sep 11. Eur J Med Chem. 2021. PMID: 34534838

6

Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution.

Ding R, Wang X, Fu J, Chang Y, Li Y, Liu Y, Liu Y, Ma J, Hu J. Ding R, et al. Among authors: hu j. Eur J Med Chem. 2022 Jul 5;237:114398. doi: 10.1016/j.ejmech.2022.114398. Epub 2022 Apr 19. Eur J Med Chem. 2022. PMID: 35468515

7

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFR^L858R/T790M inhibitors.

Fu J, Yu J, Zhang X, Chang Y, Fan H, Dong M, Li M, Liu Y, Hu J. Fu J, et al. Among authors: hu j. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2205605. doi: 10.1080/14756366.2023.2205605. J Enzyme Inhib Med Chem. 2023. PMID: 37106478 Free PMC article.

8

Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents.

Liu Y, Zhou Q, Huo Y, Sun X, Hu J. Liu Y, et al. Among authors: hu j. Eur J Med Chem. 2024 Apr 5;269:116313. doi: 10.1016/j.ejmech.2024.116313. Epub 2024 Mar 15. Eur J Med Chem. 2024. PMID: 38503168 Review.

9

Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy.

Li Y, Lv Y, Zhang C, Fu B, Liu Y, Hu J. Li Y, et al. Among authors: hu j. Eur J Med Chem. 2023 Sep 5;257:115477. doi: 10.1016/j.ejmech.2023.115477. Epub 2023 May 18. Eur J Med Chem. 2023. PMID: 37210839 Review.

10

Recent research advances in ATX inhibitors: An overview of primary literature.

Zhang C, Liu Y, Zhou Q, Fan H, Liu X, Hu J. Zhang C, et al. Among authors: hu j. Bioorg Med Chem. 2023 Jul 15;90:117374. doi: 10.1016/j.bmc.2023.117374. Epub 2023 Jun 15. Bioorg Med Chem. 2023. PMID: 37354726 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,780 results

Search Page

Filters